- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07682727
Leveraging Behavioral Economics to Understand and Improve Financial Decision Making Among Vulnerable Older Adults (Discovery)
2. července 2026 aktualizováno: Abdelaziz Alsharawy, The University of Texas Health Science Center, Houston
Leveraging Behavioral Economics to Understand and Improve Financial Decision Making Among Vulnerable Older Adults
This study seeks to:
- Identify behavioral preference patterns that characterize older adults vulnerable to financial exploitation.
- Estimate the extent to which biases in decision-making process influence financial decisions among older adults vulnerable to financial exploitation to refine information content and behavioral 'nudge' strategies.
Přehled studie
Postavení
Zatím nenabíráme
Typ studie
Pozorovací
Zápis (Odhadovaný)
400
Kontakty a umístění
Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.
Studijní kontakt
- Jméno: Abdelaziz Alsharawy, PhD
- Telefonní číslo: (713) 500-9000
- E-mail: Abdelaziz.Alsharawy@uth.tmc.edu
Studijní místa
-
-
Texas
-
Houston, Texas, Spojené státy, 77030
- The University of Texas Health Science Center at Houston
-
-
Kritéria účasti
Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Ano
Metoda odběru vzorků
Vzorek nepravděpodobnosti
Studijní populace
For online-only participation, 200 older adults (OAs) recruited via Prolific, a crowdsourcing platform.
Those participating in-lab at the Health Decision Science Lab will include 200 OAs recruited from the Houston area (that is, participants who signed up to the study team's SONA system database).
Popis
Inclusion Criteria:
- Adults over the age of 60
- English speakers, to ensure comprehension of study tasks
Exclusion Criteria:
- Less than age 60
- Non-English speaker
Studijní plán
Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.
Jak je studie koncipována?
Detaily designu
Kohorty a intervence
Skupina / kohorta |
|---|
|
Older Adults who are less vulnerable to financial exploitation
Vulnerability to financial exploitation will be assessed via the Financial Exploitation Vulnerability Scale (FEVS) assessment.
|
|
Older Adults who are more vulnerable to financial exploitation
Vulnerability to financial exploitation will be assessed via the Financial Exploitation Vulnerability Scale (FEVS) assessment.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Frequency of choosing the riskier option on the risk tolerance decision-making task
Časové okno: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize risk tolerance (willingness to accept uncertain outcomes).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the more trusting option on the trust decision-making task
Časové okno: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize interpersonal trust (willingness to accept being vulnerable to other people).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the more altruistic option on the altruism decision-making task
Časové okno: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize altruism (willingness to incur a financial cost to benefit another person).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the more patient option on the impatience decision-making task
Časové okno: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize patience (willingness to forego a sooner reward for a bigger future reward).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Frequency of choosing the less loss-averse option on the loss-aversion decision-making task
Časové okno: During the time of the decision-making task (about 5-10 minutes)
|
Participants will complete a decision-making session that captures multiple dimensions of behavioral preferences via incentivized choice-based tasks with real monetary rewards.
The study team will administer the following decision-making task via a web-based survey platform to characterize loss aversion (tendency to weigh potential losses more heavily than equivalent gains).
The task involves multiple rounds (between 20 to 40) that vary option-specific information to facilitate mapping of elicited behavioral responses onto parameters characterizing standard utility functions.
|
During the time of the decision-making task (about 5-10 minutes)
|
|
Physiological arousal as measured via heart rate
Časové okno: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Physiological arousal as measured via skin conductance
Časové okno: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Physiological arousal as measured via pupil dilation
Časové okno: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Frequency of facial expressions associated with valence and engagement
Časové okno: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
Facial expressions will be assessed using a facial expression analysis system (iMotions software).
|
During the time of the decision-making tasks (about 20-40 minutes)
|
|
Attention as assessed by eye fixations
Časové okno: During the time of the decision-making tasks (about 20-40 minutes)
|
Participants recruited for in-lab sessions will complete the decision-making tasks while also sitting before a monitor with an eye-tracker to monitor attention, a webcam to monitor facial expressions, and with a wireless device (non-invasive transmitter placed on participant's wrist with two electrodes attached to finger) worn to monitor physiological measurements (heart rate and skin conductance) while completing the choice-based tasks.
Relative fixation duration on each option in the behavioral tasks will be measured via an eye tracker (SmartEye).
|
During the time of the decision-making tasks (about 20-40 minutes)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Response time during the behavioral tasks
Časové okno: During the time of the decision-making tasks (about 20-40 minutes)
|
Response time will be reported as the time from stimulus presentation to choice, in milliseconds.
|
During the time of the decision-making tasks (about 20-40 minutes)
|
Spolupracovníci a vyšetřovatelé
Zde najdete lidi a organizace zapojené do této studie.
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Abdelaziz Alsharawy, PhD, The University of Texas Health Science Center, Houston
Termíny studijních záznamů
Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.
Hlavní termíny studia
Začátek studia (Odhadovaný)
1. srpna 2026
Primární dokončení (Odhadovaný)
1. prosince 2027
Dokončení studie (Odhadovaný)
1. prosince 2027
Termíny zápisu do studia
První předloženo
26. června 2026
První předloženo, které splnilo kritéria kontroly kvality
26. června 2026
První zveřejněno (Aktuální)
6. července 2026
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
7. července 2026
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
2. července 2026
Naposledy ověřeno
1. července 2026
Více informací
Termíny související s touto studií
Další identifikační čísla studie
- HSC-SPH-25-0344 (Discovery)
- P30AG086563 (Grant/smlouva NIH USA)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
NE
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Ne
Studuje produkt zařízení regulovaný americkým úřadem FDA
Ne
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .